
Cigna Corporation
Cigna Corporation (CI) Free Cash Flow & Analysis
Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.
CI · free cash flow · updated Jun 8, 2026
Core FCF metrics
CI · FCF · TTM · margin & CAGRFree cash flow was $8.39B for FY2025 (fiscal year ending 2025-12-31), down 6.3% year-over-year The FCF margin was 3.0%. Five-year CAGR stands at -1.9%.
Annual free cash flow history
Annual free cash flow data
FCF valuation metrics
CI · P/FCF · FCF yield · FCF per shareCigna Corporation (CI) trades at a FCF yield of 10.00% and a price-to-free-cash-flow ratio of 10.1x. FCF per share stands at $28.80, calculated using trailing twelve-month FCF divided by basic weighted-average shares outstanding.
Cash flow statement summary
CI · cash flow statement · operating / investing / financingFor FY2025, Cigna Corporation generated $9.60B in operating cash flow and spent 1.21B in capital expenditures, yielding $8.39B in free cash flow.
For the complete Operating / Investing / Financing line-item breakdown:
View Full Cash Flow Statement →Free cash flow vs peers (Healthcare)
About Free Cash Flow & Methodology
Cigna Corporation (CI) reported free cash flow of $8.39B for FY2025 (fiscal year ending 2025-12-31), down 6.3% year-over-year. The FCF margin was 3.0%.
Based on available data, Cigna Corporation has maintained positive free cash flow for at least 15 fiscal year(s). FCF peaked at $10.24B in FY2023. The 5-year CAGR stands at -1.9%.
Cigna Corporation's FCF yield is 10.00% and price-to-FCF ratio is 10.1x for FY2025, based on the latest available data.
Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.
Frequently asked questions
CI free cash flow · 8 questionsCigna Corporation free cash flow was $8.39B for FY2025, down 6.3% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at $7.66B.
▸ Source: FMP /cash-flow-statement · US GAAP · Cigna Corporation · Cigna Corporation SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026